126
Views
1
CrossRef citations to date
0
Altmetric
CASE SERIES

Scedosporium apiospermum and Lichtheimia corymbifera Co-Infection Due to Inhalation of Biogas in Immunocompetent Patients: A Case Series

, , & ORCID Icon
Pages 6423-6430 | Received 31 Aug 2022, Accepted 27 Oct 2022, Published online: 02 Nov 2022

References

  • Bandres MV, Modi P, Sharma S. Aspergillus fumigatus. In: StatPearls; 2022.
  • Feng J, Sun X. Characteristics of pulmonary mucormycosis and predictive risk factors for the outcome. Infection. 2018;46(4):503–512. doi:10.1007/s15010-018-1149-x
  • Skiada A, Pavleas I, Drogari-Apiranthitou M. Epidemiology and diagnosis of mucormycosis: an update. J Fungi. 2020;6(4):32.
  • Cornely OA, Alastruey-Izquierdo A, Arenz D, et al. Global guideline for the diagnosis and management of mucormycosis: an initiative of the European confederation of medical mycology in cooperation with the Mycoses study group education and research consortium. Lancet Infect Dis. 2019;19(12):e405–e421. doi:10.1016/S1473-3099(19)30312-3
  • Roden MM, Zaoutis TE, Buchanan WL, et al. Epidemiology and outcome of zygomycosis: a review of 929 reported cases. Clin Infect Dis. 2005;41(5):634–653. doi:10.1086/432579
  • Petrikkos G, Skiada A, Lortholary O, Roilides E, Walsh TJ, Kontoyiannis DP. Epidemiology and clinical manifestations of mucormycosis. Clin Infect Dis. 2012;54(Suppl 1):S23–34. doi:10.1093/cid/cir866
  • Caston JJ, Linares MJ, Rivero A, Casal M, Torre-Cisneros J. Clinical differences between invasive pulmonary infection by Scedosporium apiospermum and invasive pulmonary aspergillosis. Mycoses. 2011;54(5):e468–73. doi:10.1111/j.1439-0507.2010.01952.x
  • Cortez KJ, Roilides E, Quiroz-Telles F, et al. Infections caused by Scedosporium spp. Clinical microbiology reviews. Clin Microbiol Rev. 2008;21(1):157–197. doi:10.1128/CMR.00039-07
  • Liu W, Feng RZ, Jiang HL. Scedosporium spp lung infection in immunocompetent patients: a systematic review and MOOSE-compliant meta-analysis. Medicine. 2019;98(41):e17535. doi:10.1097/MD.0000000000017535
  • Rodriguez-Tudela JL, Berenguer J, Guarro J, et al. Epidemiology and outcome of Scedosporium prolificans infection, a review of 162 cases. Med Mycol. 2009;47(4):359–370. doi:10.1080/13693780802524506
  • Seidel D, Meissner A, Lackner M, et al. Prognostic factors in 264 adults with invasive Scedosporium spp. and Lomentospora prolificans infection reported in the literature and FungiScope((R)). Crit Rev Microbiol. 2019;45(1):1–21. doi:10.1080/1040841X.2018.1514366
  • Watanabe S, Anzawa K, Mochizuki T. Case of mycotic cyst caused by Scedosporium apiospermum developed liver dysfunction following administration of voriconazole. J Dermatol. 2017;44(11):e296–e297. doi:10.1111/1346-8138.13980
  • He XH, Wu JY, Wu CJ, Halm-Lutterodt NV, Zhang J, Li CS. Scedosporium Apiospermum Infection after Near-drowning. Chin Med J. 2015;128(15):2119–2123. doi:10.4103/0366-6999.161401
  • David NGHFC, Michael SS. The Sanford Guide to Antimicrobial Therapy 2020. 范洪伟. 50 ed. Peking Union Medical College Press;2021.
  • Shand JM, Albrecht RM, Burnett HF 3rd, Miyake A. Invasive fungal infection of the midfacial and orbital complex due to Scedosporium apiospermum and mucormycosis. J Oral Maxillofac Surg. 2004;62(2):231–234. doi:10.1016/j.joms.2003.04.013
  • Vacher G, Niculita-Hirzel H, Roger T. Immune responses to airborne fungi and non-invasive airway diseases. Semin Immunopathol. 2015;37(2):83–96. doi:10.1007/s00281-014-0471-3
  • Jeong W, Keighley C, Wolfe R, et al. The epidemiology and clinical manifestations of mucormycosis: a systematic review and meta-analysis of case reports. Clin Microbiol Infect. 2019;25(1):26–34. doi:10.1016/j.cmi.2018.07.011
  • Sharma A, Goel A. Mucormycosis: risk factors, diagnosis, treatments, and challenges during COVID-19 pandemic. Folia Microbiol. 2022. doi: 10.1007/s12223-021-00934-5
  • DeSimone MS, Crothers JW, Solomon IH, Laga AC. Scedosporium and lomentospora infections are infrequent, difficult to diagnose by histology, and highly virulent. Am J Clin Pathol. 2021;156(6):1044–1057. doi:10.1093/ajcp/aqab070
  • Kaur H, Ghosh A, Rudramurthy SM, Chakrabarti A. Gastrointestinal mucormycosis in apparently immunocompetent hosts-A review. Mycoses. 2018;61(12):898–908. doi:10.1111/myc.12798
  • Lamoth F, Kontoyiannis DP. Therapeutic challenges of non-aspergillus invasive mold infections in immunosuppressed patients. Antimicrob Agents Chemother. 2019;63(11):23.
  • Husain S, Capitano B, Corcoran T, et al. Intrapulmonary disposition of amphotericin B after aerosolized delivery of amphotericin B lipid complex (Abelcet; ABLC) in lung transplant recipients. Transplantation. 2010;90(11):1215–1219. doi:10.1097/TP.0b013e3181f995ea
  • Patterson TF, Thompson GR 3rd, Denning DW, et al. Practice guidelines for the diagnosis and management of aspergillosis: 2016 update by the Infectious Diseases Society of America. Clin Infect Dis. 2016;63(4):e1–e60. doi:10.1093/cid/ciw326